Qu J Q, Zhong L, Masoom-Yasinzai M, Abdur-Rab M, Aksu H S, Reed S G, Chang K P, Gilman-Sachs A
Department of Microbiology/Immunology, University of Health Sciences/Chicago Medical School, North Chicago, Illinois 60064.
Trans R Soc Trop Med Hyg. 1994 Sep-Oct;88(5):543-5. doi: 10.1016/0035-9203(94)90154-6.
rK39 is a recombinant product of the 39 amino acid repeats found in a kinesin-like gene of visceral Leishmania spp. This and other antigens were compared for immunodiagnostic potential by enzyme-linked immunosorbent assay with sera from confirmed cases of Asian cutaneous and visceral leishmaniasis. In preliminary trials, rK39 proved superior to 2 purified Leishmania antigens, a cytosolic protein (p36) and a membrane protein (gp63), for immunodiagnosis of visceral leishmaniasis. Of the 53 visceral cases from China and Pakistan assayed, 52 were seropositive (98%) at a 10(-1) dilution with 36 ng of rK39. End point titrations of 27 highly positive samples yielded anti-rK39 antibody titres ranging from c. 10(-3) to beyond 10(-4). Antigen titrations with one positive serum further revealed that rK39 was 25-fold more sensitive than Leishmania whole cell soluble lysates. 31 cutaneous leishmaniasis cases from Turkey assayed for anti-rK39 antibody gave reactions ranging from negative or marginally positive to positive. In Brazil, all cutaneous and mucocutaneous leishmaniasis cases gave negative results in this assay.
rK39是在内脏利什曼原虫属的一种驱动蛋白样基因中发现的39个氨基酸重复序列的重组产物。通过酶联免疫吸附测定法,将该抗原及其他抗原与亚洲皮肤利什曼病和内脏利什曼病确诊病例的血清进行比较,以评估其免疫诊断潜力。在初步试验中,rK39在用于内脏利什曼病的免疫诊断方面,被证明优于两种纯化的利什曼原虫抗原,一种是胞质蛋白(p36),另一种是膜蛋白(gp63)。在对来自中国和巴基斯坦的53例内脏病例进行检测时,用36 ng的rK39在10(-1)稀释度下检测,52例呈血清阳性(98%)。对27个高度阳性样本进行终点滴定,得到的抗rK39抗体滴度范围约为10(-3)至超过10(-4)。用一份阳性血清进行抗原滴定进一步显示,rK39的敏感性比利什曼原虫全细胞可溶性裂解物高25倍。对来自土耳其的31例皮肤利什曼病病例检测抗rK39抗体,结果从阴性或弱阳性到阳性不等。在巴西,所有皮肤和黏膜皮肤利什曼病病例在该检测中均呈阴性结果。